With GLP-1 users' limited daily caloric intake, products need to have sufficient nutritional value or smaller serving size
GLP-1 receptors are expressed in various tissues and organs including liver, kidneys, peripheral and central nervous system, endocrine glands, skeletal muscles and epicardial adipose tissue
However, newer evidence suggests that pharmacologic therapy can reduce fat mass while preserving or enhancing muscle performance
*Obesity GLP-1 Wegovy and Zepbound Source: IQVIA Analysis
Emerging research may also reveal new applications for GLP-1 beyond alcohol cravings, such as its impact on other substance use disorders, such as cocaine and opioid addictions
A research ethics board approved this study prior to all chart review activities